BWAY
BrainswayยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BWAY Profile
Brainsway Ltd.
A global leader in the advanced noninvasive treatment of brain disorders
Healthcare Equipment and Supplies
11/07/2006
04/17/2019
NASDAQ Stock Exchange
120
12-31
Depository Receipts (Ordinary Shares)
16 Hartum Street, RAD Tower, 14th Floor, Har HaHotzvim, Jerusalem, 9777516, Israel
Focus on the development and sale of non-invasive neuromodulation products.
Brainsway Ltd., was incorporated under the laws of the State of Israel on November 7, 2006. The company is a global leader in advanced non-invasive neurostimulation for the treatment of mental health disorders. The company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. The company is committed to leading through superior science and building on what is considered to be unparalleled clinical evidence. The company is the first and only TMS company to receive U.S. Food and Drug Administration (FDA) approval for three separate mental health disorder indications based on clinically proven efficacy, as demonstrated in a pivotal randomized placebo-controlled study. Current indications include major depression (MDD) (including the reduction of comorbid anxiety symptoms, commonly referred to as anxiety depression), obsessive-compulsive disorder (OCD), and smoking addiction.
